Patients with hypertension: 2 trials - ABCD target (H) - ABCD target (N)
| more intensive blood pressure lowering strategie vs less intensive blood pressure lowering strategie | No demonstrated result suggested non cardiovascular death by 59% (not demonstrated) |
All type of patients: 17 trials - MDRD - HOT - ABCD target (H) - AASK - REIN-2 - ABCD target (N) - Toto - ACCORD blood pressure - Cardio-Sis - SPRINT - UKPDS-HDS - JATOS - VANLISH - HOMED-BP - SPS3 - Wei - PAST-BP
| more intensive blood pressure lowering strategie vs less intensive blood pressure lowering strategie | No demonstrated result suggested cardiovascular events by 17% (not demonstrated) suggested Cardiovascular death by 16% (not demonstrated) suggested myocardial infarction (fatal and non fatal) by 14% (not demonstrated) suggested stroke (fatal and non fatal) by 17% (not demonstrated) suggested Serious adverse event by 104% (not demonstrated) suggested Heart failure by 27% (not demonstrated) suggested left ventricular hypertrophy by 33% (not demonstrated) suggested End stage renal disease by 15% (not demonstrated) suggested All cause death by 11% (not demonstrated) |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
